Atlas Trials

Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study

Clinical trial NCT02269969 · COMPLETED

Trial details

NCT number
NCT02269969
Sponsor
Sandra Walker
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
BurnsInfection
Start date
2015-03-01
Primary completion
2015-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.